Pharmaceutical

Subscribe

TRENTON, N.J. — Johnson & Johnson has named Alex Gorsky as CEO, effective April 26, according to a press release. Gorsky will succeed Bill Weldon, who has served as

FORT WASHINGTON, Pa. — Johnson & Johnson’s McNeil Consumer Healthcare unit is voluntarily recalling approximately 574,000 bottles of infant Tylenol due to complaints about the SimpleMeasure™ dosing system, according

NEW YORK — Speaking at an investor conference in New York on Tuesday, Pfizer Inc. research chief Mikael Dolsten said the company’s experimental treatment for Alzheimer''s disease is the

MEMPHIS, Tenn. — Medical device manufacturer Smith & Nephew announced Monday that it will pay $22 million to settle claims that it won business in Greece by bribing doctors,

BRENTFORD, UK — The UK’s biggest drugmaker GlaxoSmithKline Plc has agreed to settle 20,000 more lawsuits alleging its diabetes medication Avandia caused heart attacks, Bloomberg reported. The company has

NEW YORK — Pfizer is recalling about 1 million birth control pills due to a packaging error that could increase the likelihood of pregnancy, according to a press release.

GENEVA, Switzerland — On Monday, the research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases

WASHINGTON — The U.S. Justice Department filed a "ground-breaking" consent decree in court for a permanent injunction mandating Indian drug-maker Ranbaxy to adhere to U.S. manufacturing standards and ensure

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan;

BANGALORE and MUMBAI — U.S.-based Watson Pharmaceuticals Inc said it bought the Australian and South East Asian generic drugs business of Strides Arcolab for A$375 million, reports Reuters.